The first New Zealand-made medicinal cannabis products are expected to be in pharmacy shelves before Christmas, TVNZ reports. It was made possible with Medicinal cannabis company Helius having received its good manufacturing practice (GMP) certification; the first firm to receive a licence to begin production. According to Helius Therapeutics chief executive Carmen Doran, the company still needs to work with the Medicinal Cannabis Agency and provide information to ensure its products meet New Zealand’s quality standards.
Recent Comments